A closer look at GENI’s price-to-free cash flow ratio

Genius Sports Limited (GENI)’s stock is trading at $9.98 at the moment marking a fall of -0.97% from the last session close. As of this writing, shares are priced at -12.44% less than their 52-week high of $11.40, and 94.96% over their 52-week low of $5.12. Based on the past 30-day period, the stock price is -4.29% below the high and +9.48% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, GENI’s SMA-200 is $9.06.

Further, it is important to consider GENI stock ratios, particularly its price-to-sales ratio over the past twelve months, which stands at 4.74.Likewise, its price to free cash flow for the last twelve months stands at 66.37. GENI’s price to book ratio for the most recent quarter was 3.68, resulting in an 10.77 price to cash per share for the period.

How does Genius Sports Limited (GENI) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 14 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.93 in simple terms.

Genius Sports Limited (GENI): Earnings History

In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$0.06 in contrast with the Outlook of -$.

Genius Sports Limited (GENI): Earnings History

Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 3 different analysts, who are expecting earnings to fall in between the range of 0.05 and -0.01 with an average Earnings Estimate of 0.01 which is in contrast with the last year earnings estimate of -0.09 and also replicates 111.11% growth rate year over year.

Genius Sports Limited (NYSE: GENI) Ownership Details

I will give a breakdown of the key shareholders in Genius Sports Limited (GENI). Recent figures show that the company’s insiders hold 8.64% of shares. A total of 258 institutional investors hold shares in the company, making 91.35% of its stock and 100.00% of its float.

Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Caledonia (Private) Investments Pty Ltd holding total of 15.02 shares that make 6.98% of the company’s total number of shares and are currently priced at 150.05 million.

The securities firm Capital Research Global Investors holds 13.2 shares of GENI, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 6.13% , and the holding percentage of shares is valued at 131.85 million.

An overview of Genius Sports Limited’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Genius Sports Limited (GENI) traded 3,714,078 shares per day, with a moving average of $9.71 and price change of +0.07. With the moving average of $10.08 and a price change of +0.48, about 4,151,547 shares changed hands on average over the past 50 days. Finally, GENI’s 100-day average volume is 3,827,748 shares, alongside a moving average of $9.77 and a price change of +1.11.

Hot this week

Procept BioRobotics Corp (PRCT)’s stock chart: A technical perspective

While Procept BioRobotics Corp has underperformed by -1.13%, investors...

Chewy Inc (CHWY)’s stock performance: a year in review

While Chewy Inc has overperformed by 2.45%, investors are...

Arcus Biosciences Inc (RCUS)’s stock price in review: A technical analysis

While Arcus Biosciences Inc has overperformed by 0.47%, investors...

A closer look at Edgewell Personal Care Co (EPC)’s stock price trends

While Edgewell Personal Care Co has overperformed by 0.51%,...

Arrowhead Pharmaceuticals Inc (ARWR)’s stock rises to 22.34 per share

While Arrowhead Pharmaceuticals Inc has overperformed by 2.52%, investors...

Topics

Procept BioRobotics Corp (PRCT)’s stock chart: A technical perspective

While Procept BioRobotics Corp has underperformed by -1.13%, investors...

Chewy Inc (CHWY)’s stock performance: a year in review

While Chewy Inc has overperformed by 2.45%, investors are...

Arcus Biosciences Inc (RCUS)’s stock price in review: A technical analysis

While Arcus Biosciences Inc has overperformed by 0.47%, investors...

A closer look at Edgewell Personal Care Co (EPC)’s stock price trends

While Edgewell Personal Care Co has overperformed by 0.51%,...

Arrowhead Pharmaceuticals Inc (ARWR)’s stock rises to 22.34 per share

While Arrowhead Pharmaceuticals Inc has overperformed by 2.52%, investors...

Yext Inc (YEXT) stock analysis: A comprehensive overview

While Yext Inc has overperformed by 0.22%, investors are...

Zevra Therapeutics Inc (ZVRA)’s stock price range in the last year

While Zevra Therapeutics Inc has underperformed by -0.64%, investors...

Kontoor Brands Inc (KTB) stock: A year of ups and downs

While Kontoor Brands Inc has underperformed by -1.58%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.